ELIXIRGEN THERAPEUTICS
Elixirgen Therapeutics is a biotechnology company focused on curing humanityโs ailments through stem cell biology. The company concentrates on regenerative and rejuvenative medicine, and deals with research in both basic science and in the application of the technologies it discovers and refines. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore, an ideal research environment that allows Elixirgen Therapeuticsโ scientists to conduct research at state-of-the-art facilities. Elixirgen Therapeutics inherits all the therapy-related assets, including intellectual property, from its parent company, Elixirgen, LLC, which has been in active operation since the beginning of 2012.
ELIXIRGEN THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.elixirgentherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(443) 869-5420
Email Addresses:
[email protected]
Total Funding:
13.98 M USD
Technology used in webpage:
SPF Google Apps For Business GoDaddy DNS Pound Sterling Japanese Yen GoDaddy
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Series A - Elixirgen Therapeutics
Official Site Inspections
http://www.elixirgentherapeutics.com
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Elixirgen Therapeutics"
Elixirgen Therapeutics, Inc. - LinkedIn
About us Elixirgen Therapeutics is a clinical-stage RNA therapeutics company focused on the discovery and development of innovative therapies, including cell and gene therapies. The โฆSee details»
Elixirgen Therapeutics - Crunchbase Company Profile
Elixirgen Therapeutics is a biotechnology company that specializes in the development of therapies for genetic diseases and vaccines.See details»
Elixirgen Therapeutics
We develop life-changing therapies, focusing on rare diseases and aging-associated diseases using our cutting-edge technologies.See details»
Elixirgen Therapeutics, Inc. - UTEC-The University of Tokyo Edge ...
Elixirgen Therapeutics, Inc.๏ฝOur Companies of Introduction.UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.See details»
Elixirgen Therapeutics - VentureRadar
Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of therapies for genetic diseases and vaccines.See details»
Elixirgen Therapeutics - Org chart | The Org
Explore Elixirgen Therapeutics' organizational chart. Discover current team members including executives, board members, and advisors.See details»
Elixirgen Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EXG-34217 for Treatment of Telomere Biology Disorders | Elixirgen Fast โฆSee details»
Elixirgen Therapeutics - Overview, News & Similar companies
View Elixirgen Therapeutics (www.elixirgentherapeutics.com) location in Maryland, United States , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
Elixirgen Therapeutics, Inc. Company Overview, Contact Details ...
Nov 9, 2023 Elixirgen Therapeutics, Inc. Biotechnology Research Maryland, United States 11-50 Employees Elixirgen Therapeutics is a clinical-stage RNA therapeutics company focused on โฆSee details»
ELIXIRGEN THERAPEUTICS, INC. - Biotechnology | Tiny Tech Fund
Elixirgen Therapeutics, Inc. is a cutting-edge biotechnology firm dedicated to the development of innovative RNA therapeutics aimed at addressing a broad spectrum of medical challenges. โฆSee details»
Elixirgen Therapeutics 2025 Company Profile: โฆ
Information on valuation, funding, cap tables, investors, and executives for Elixirgen Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Elixirgen Therapeutics, Inc. Company Profile | Baltimore, MD ...
Find company research, competitor information, contact details & financial data for Elixirgen Therapeutics, Inc. of Baltimore, MD. Get the latest business insights from Dun & Bradstreet.See details»
Elixirgen Therapeutics - 2025 Company Profile & Team - Tracxn
Jun 21, 2025 Elixirgen Therapeutics is a series A company based in Baltimore (United States), founded in 2012 by Minoru Ko. It operates as a Developer of RNA therapeutics to treat โฆSee details»
Elixirgen Therapeutics Granted FDA Regenerative Medicine โฆ
BALTIMORE, Feb. 13, 2025 (GLOBE NEWSWIRE) โ Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the โฆSee details»
How Elixirgen Manufactures Hematopoietic Stem Cells At The โฆ
Oct 9, 2024 An FDA rare pediatric disease designation recently pushed extra wind into the sails of Elixirgen Therapeutics, an RNA cell therapy company. With a Phase 1/2 trial to treat โฆSee details»
Elixirgen Therapeutics - Profiles & Contacts - Crunchbase
Elixirgen Therapeutics is a biotechnology company that specializes in the development of therapies for genetic diseases and vaccines.See details»
Elixirgen Therapeutics - Contacts, Employees, Board Members, โฆ
Elixirgen Therapeutics is a biotechnology company that specializes in the development of therapies for genetic diseases and vaccines.See details»
Elixirgen Therapeutics Granted FDA Orphan Drug Designation
Feb 20, 2025 The Orphan Drug Designation qualifies Elixirgen Therapeuticsโ EXG-34217 program for various incentives that assist in the drug development process including tax โฆSee details»
Elixirgen Therapeutics Granted FDA Orphan Drug Designation for โฆ
Feb 20, 2025 The Orphan Drug Designation qualifies Elixirgen Therapeuticsโ EXG-34217 program for various incentives that assist in the drug development process including tax โฆSee details»
Elixirgen Therapeutics Partners with Taisho Pharmaceutical on ...
BALTIMORE, March 7, 2022 โ Elixirgen Therapeutics, Inc., a Baltimore-based platform biotechnology company focused on the discovery and development of therapies for genetic โฆSee details»